N. Hallab et al., Hypersensitivity to metallic biomaterials: a review of leukocyte migrationinhibition assays, BIOMATERIAL, 21(13), 2000, pp. 1301-1314
Metal hypersensitivity is a well-established phenomenon occurring in a vari
ety of domestic and workplace settings. Degradation products of metallic bi
omaterials may mediate metal hypersensitivity. However, little is known abo
ut the short- and long-term pharmacodynamics and bioavailability of circula
ting metal degradation products in vivo. Mechanisms by which in vivo metal
sensitivity reactions occur have not been well characterized and the degree
to which metal sensitivity may be a predisposing factor for eliciting an o
veraggressive immune response remains clinically unpredictable. In vitro le
ukocyte migration inhibition assays have been used for investigating cell-m
ediated hypersensitivity reactions to biomaterial and biomaterial degradati
on products. This review provides a historical and technical summary of fou
r in vitro techniques used for determination of leukocyte migration activit
y: (1) membrane migration or Boyden chamber, (2) capillary tube, (3) leukoc
yte migration using agarose technique, and (4) collagen gels. It is difficu
lt to determine which, if any, of these techniques is singularly best suite
d for the investigation of suspected biomaterial-related symptoms in patien
ts. However, Boyden chamber membrane migration testing is recommended for c
linical investigations, principally because a high degree of standardized i
nvestigator independent materials and methodologies is necessary for compil
ing and comparing the results of patients tested at various times over the
length of an extended study. Ultimately, in vitro migration inhibition test
ing has the potential to provide a reliable means for predicting some compl
ications and thus enhancing the outcome for patients receiving metallic imp
lants. Continuing improvements in migration inhibition testing methods, use
d alone or in combination with other immunologic assays, will likely improv
e assessment of patients susceptible to biomaterial antigen-induced delayed
-type hypersensitivity responses. (C) 2000 Elsevier Science Ltd. All rights
reserved.